高危浅表性上尿路移行细胞癌的临床试验
总计3147个结果
-
McGill University Health Centre/Research Institute...University of British Columbia; University of Iowa; University of North Carolina, Chapel Hill; Lawson... 和其他合作者招聘中先兆子痫 | 动脉硬化 | 高危妊娠加拿大
-
Sunnybrook Health Sciences CentreProstate Cancer Canada未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
M.D. Anderson Cancer CenterAstraZeneca招聘中
-
Massachusetts General HospitalBiocompatibles UK Ltd招聘中
-
Noah Hahn, M.D.AstraZeneca; Hoosier Cancer Research Network招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...主动,不招人
-
SCRI Development Innovations, LLCBayer; Boehringer Ingelheim; Exelixis; Foundation Medicine完全的
-
Dana-Farber Cancer InstituteBristol-Myers Squibb主动,不招人肾上腺皮质癌 | 阴茎癌 | 泌尿生殖系统癌症 | 非尿路上皮膀胱 | 非尿路上皮上尿道 | 非腺癌 前列腺癌 | 难治性生殖细胞 | 高级别神经内分泌癌/小细胞癌美国
-
Heinrich-Heine University, DuesseldorfAbiomed Inc.; Profil Clinical Trials Coordination GmbH招聘中
-
Dana-Farber Cancer InstituteBlue Earth Diagnostics主动,不招人
-
AnchorDx Medical Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Peking University People's Hospital 和其他合作者完全的
-
National Cancer Institute (NCI)招聘中
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC主动,不招人
-
The Methodist Hospital Research InstitutePfizer招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb主动,不招人
-
M.D. Anderson Cancer Center招聘中小细胞肺癌 | 霍奇金淋巴瘤 | 宫颈癌 | 腹膜间皮瘤 | 胸膜间皮瘤 | 神经内分泌癌 | 微卫星高位癌 | 肺外高级别美国
-
Sumitomo Pharma Switzerland GmbH招聘中
-
Hamad Medical CorporationSidra Medical and Research Center尚未招聘
-
Louise KennyErasmus Medical Center; University of Liverpool; Copenhagen Trial Unit, Center for Clinical Intervention... 和其他合作者未知
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
Dana-Farber Cancer InstituteEMD Serono; National Comprehensive Cancer Network招聘中
-
National Cancer Institute (NCI)主动,不招人转移性尿路上皮癌 | III 期膀胱尿路上皮癌 AJCC v6 和 v7 | IV 期膀胱尿路上皮癌 AJCC v7 | 局部晚期尿路上皮癌 | 复发性尿路上皮癌 | 不可切除的尿路上皮癌 | 晚期尿路上皮癌美国
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止III期肾细胞癌 | 复发性膀胱癌 | 第一阶段前列腺癌 | III期前列腺癌 | 浸润性膀胱尿路上皮癌 | II期膀胱尿路上皮癌 | IIA 期前列腺癌 | IIB 期前列腺癌 | I期肾细胞癌 | II期肾细胞癌美国
-
Sumitomo Pharma Switzerland GmbH尚未招聘妊娠并发症 | 怀孕相关 | 怀孕,高风险
-
National Cancer Institute (NCI)招聘中III 期膀胱尿路上皮癌 AJCC v6 和 v7 | IV 期膀胱尿路上皮癌 AJCC v7 | II 期膀胱尿路上皮癌 AJCC v6 和 v7 | 肌肉浸润性膀胱尿路上皮癌美国
-
Verity Pharmaceuticals Inc.尚未招聘膀胱癌 | 膀胱尿路上皮癌 | 膀胱癌复发 | 肿瘤复发 | 尿路上皮癌复发 | 非浸润性膀胱尿路上皮癌
-
University of OxfordKing's College London; University of Southampton; Barts & The London NHS Trust; University of Birmingham 和其他合作者完全的
-
Mirati Therapeutics Inc.终止
-
National Cancer Institute (NCI)完全的
-
Ontario Clinical Oncology Group (OCOG)Cancer Care Ontario主动,不招人